Trial intelligence / Profile preview

Islet Allotransplant with Delayed MMF in Type 1 Diabetes

NCT00285233Phase 2Completed

Sponsor
University of Minnesota
Start
Sep 2000
Primary completion
Sep 2004
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by University of Minnesota. Started Sep 2000; status: completed.

02

Drugs

donislecel
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00285233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00285233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call